Stockreport

Barinthus Bio Reports Full Year 2024 Financial Results and Updates on Corporate Developments

Barinthus Biotherapeutics plc - American Depositary Shares  (BRNS) 
PDF Strategic transformation ongoing, positioning the Company as a focused leader in immunology and inflammatory diseasesHighly differentiated, potentially curative immunoth [Read more]